Vimarsana
Biggest News Aggregation in the World

Page 4 - Dirk Neum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Neum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Neum Today - Breaking & Trending Today

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG - adhoc - Börsennachrichten - Vimarsana News

EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG - adhoc - Börsennachrichten

EQSAdhoc Biotest AG Key word Personnel Biotest AG Peter Janssen appointed new Chairman of the Board of Biotest AG 05Oct2023 1642 CETCEST Disclosure of an inside information acc to Article 17 MAR of t

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance - Vimarsana News

EQS-Adhoc: Biotest AG: Increase of the EBIT guidance

EQS-Ad-hoc: Biotest AG / Key word(s): Change in Forecast Biotest AG: Increase of the EBIT guidance 05-Oct-2023 / 16:55 CET/CEST ...

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK -September 21, 2023 at 03:02 am EDT - Vimarsana News

Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK -September 21, 2023 at 03:02 am EDT

EQS-News: Biotest AG / Key word: Regulatory Approval Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK 21.09.2023 / 09:00...

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin -Today at 03:02 am - Vimarsana News

Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin -Today at 03:02 am

EQS-News: Biotest AG / Key word: Study Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin...

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo -Today at 03:02 am - Vimarsana News

Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo -Today at 03:02 am

EQS-News: Biotest AG / Key word: Regulatory Admission Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin...